Cambridge Nutritional Sciences plc Stock
Equities
ODX
GB00B1VCP282
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.3 GBX | -1.49% | -1.49% | +37.50% |
Jan. 29 | Cambridge Nutritional Sciences hires first operations chief | AN |
Jan. 29 | Cambridge Nutritional Sciences plc Announces Appointment of James Cooper as Operations Director | CI |
Sales 2024 * | 9M 11.21M | Sales 2025 * | - | Capitalization | 7.97M 9.93M |
---|---|---|---|---|---|
Net income 2024 * | -1M -1.25M | Net income 2025 * | - | EV / Sales 2024 * | 0.42 x |
Net cash position 2024 * | 4.2M 5.23M | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-6.7
x | P/E ratio 2025 * |
-
| Employees | 91 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.83% |
Latest transcript on Cambridge Nutritional Sciences plc
1 day | -1.49% | ||
1 week | -1.49% | ||
Current month | -4.35% | ||
1 month | +6.45% | ||
3 months | +32.00% | ||
6 months | +91.30% | ||
Current year | +37.50% |
Managers | Title | Age | Since |
---|---|---|---|
Jag Grewal
CEO | Chief Executive Officer | 54 | 11-06-29 |
Members of the board | Title | Age | Since |
---|---|---|---|
Simon Douglas
CHM | Chairman | 65 | 21-02-10 |
Jag Grewal
CEO | Chief Executive Officer | 54 | 11-06-29 |
Jeremy Millard
BRD | Director/Board Member | 53 | 19-02-28 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-17 | 3.3 | -1.49% | 360 734 |
24-04-16 | 3.35 | 0.00% | 86,245 |
24-04-15 | 3.35 | 0.00% | 33,500 |
24-04-12 | 3.35 | 0.00% | 57,656 |
24-04-11 | 3.35 | 0.00% | 239,344 |
Delayed Quote London S.E., April 17, 2024 at 11:35 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+37.50% | 9.91M | |
-0.50% | 12.75B | |
-19.65% | 6.89B | |
-2.87% | 4.95B | |
-7.82% | 4.28B | |
-0.61% | 4.23B | |
-47.71% | 3.67B | |
+8.57% | 2.62B | |
-6.37% | 2.31B | |
-2.56% | 1.7B |
- Stock Market
- Equities
- ODX Stock